EFFECTS OF ADRENALINE, ISOPRENALINE AND FORSKOLIN ON PREGNANT HUMAN MYOMETRIAL PREPARATIONS

SUMMARY 1. The effects of adrenaline, isoprenaline and forskolin upon the evoked contractions of field‐stimulated preparations of human, pregnant, isolated myometrium have been examined. Specimens were obtained at lower segment Caesarean section from patients at 31 (n= 1) and 36–40 (n= 10) weeks of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical and experimental pharmacology & physiology 1988-09, Vol.15 (9), p.703-713
Hauptverfasser: Story, Margot E., Hall, Solveiga, Ziccone, Sebastian P., Paull, John D.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 713
container_issue 9
container_start_page 703
container_title Clinical and experimental pharmacology & physiology
container_volume 15
creator Story, Margot E.
Hall, Solveiga
Ziccone, Sebastian P.
Paull, John D.
description SUMMARY 1. The effects of adrenaline, isoprenaline and forskolin upon the evoked contractions of field‐stimulated preparations of human, pregnant, isolated myometrium have been examined. Specimens were obtained at lower segment Caesarean section from patients at 31 (n= 1) and 36–40 (n= 10) weeks of gestation. 2. Adrenaline enhanced the electrically evoked contractions of all preparations studied, indicating that its predominant action on these pregnant myometrial tissues was at α‐and not β‐adrenoceptors. 3. Isoprenaline in concentrations at and below 10 μmol/1 produced inhibitory effects in eight of 11 experiments. In the remaining three experiments, tissues were not responsive to the inhibitory effects of isoprenaline. 4. In all preparations exposed to higher concentrations of isoprenaline (30 or 100 μmol/1), its effects were excitatory. 5. Forskolin produced inhibitory effects on preparations from all uteri, including those from which tissues unresponsive to isoprenaline had been obtained. 6. It is suggested that forskolin in the concentrations which were effective in this study produced its inhibitory effects largely through activation of adenylate cyclase. This implies that the lack of an inhibitory response of some preparations to isoprenaline was not due to reduced activity of the adenylate cyclase system, but that the failure of isoprenaline to produce an inhibitory effect could be due to diminished numbers of β‐adrenoceptors and/or increased numbers of α‐adrenoceptors, or to a defect in the coupling of the receptors to the adenylate cyclase system. Alternatively, the presence of an endogenous antagonist of the effects of isoprenaline (for example, an eicosanoid), could mask its inhibitory effects. 7. The absence of an inhibitory effect of isoprenaline on some specimens of human gravid myometrium could have clinical implications, in view of the widespread use of β2‐adrenoceptor agonists as uterine relaxants.
doi_str_mv 10.1111/j.1440-1681.1988.tb01130.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78803088</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>15150057</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4383-2d44720a19fd689fccf0827c8dcc08b7d652e649e203f10f98866af423cdabe73</originalsourceid><addsrcrecordid>eNqVkUFP4zAQhS20iC0sP2Elaw97ImEcJ7a7BySrJCWidao07Gq1Byt1HKmlpRC3ovx7ErX0inYuo9Gb-Sy_h9APAj5p63rhkzAEjzBBfNIXwt_MgBAK_u4E9Y7SF9QDCpFHBIev6Ny5BQBEwOgZOqMBJ4zSHvoXJ0k8KKY4S7C8zWMlR6mKr3A6zSYfE5bqFidZPr3P2hFnCrfSUElV4LuHsVR4_Dcbx0WeylGnTGQuizRT02_otC6Xzl4e-gV6SOJicOeNsmE6kCPPhFRQL6jCkAdQkn5dMdGvjalBBNyIyhgQM16xKLAs7NsAaE2gbj_MWFmHATVVObOcXqCfe-5zs37ZWrfRq7kzdrksn-x66zQXojVCiE8XSUSi1qKO-Gu_aJq1c42t9XMzX5XNmyaguwj0Qnc-685n3UWgDxHoXXv8_fDKdray1fH04Hmr3-z11_nSvv0HWQ_iCYcO4O0Bc7exuyOgbB4145RH-o8a6kkekeS3CPQ9fQer_pyP</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>15150057</pqid></control><display><type>article</type><title>EFFECTS OF ADRENALINE, ISOPRENALINE AND FORSKOLIN ON PREGNANT HUMAN MYOMETRIAL PREPARATIONS</title><source>MEDLINE</source><source>Wiley Blackwell Single Titles</source><creator>Story, Margot E. ; Hall, Solveiga ; Ziccone, Sebastian P. ; Paull, John D.</creator><creatorcontrib>Story, Margot E. ; Hall, Solveiga ; Ziccone, Sebastian P. ; Paull, John D.</creatorcontrib><description>SUMMARY 1. The effects of adrenaline, isoprenaline and forskolin upon the evoked contractions of field‐stimulated preparations of human, pregnant, isolated myometrium have been examined. Specimens were obtained at lower segment Caesarean section from patients at 31 (n= 1) and 36–40 (n= 10) weeks of gestation. 2. Adrenaline enhanced the electrically evoked contractions of all preparations studied, indicating that its predominant action on these pregnant myometrial tissues was at α‐and not β‐adrenoceptors. 3. Isoprenaline in concentrations at and below 10 μmol/1 produced inhibitory effects in eight of 11 experiments. In the remaining three experiments, tissues were not responsive to the inhibitory effects of isoprenaline. 4. In all preparations exposed to higher concentrations of isoprenaline (30 or 100 μmol/1), its effects were excitatory. 5. Forskolin produced inhibitory effects on preparations from all uteri, including those from which tissues unresponsive to isoprenaline had been obtained. 6. It is suggested that forskolin in the concentrations which were effective in this study produced its inhibitory effects largely through activation of adenylate cyclase. This implies that the lack of an inhibitory response of some preparations to isoprenaline was not due to reduced activity of the adenylate cyclase system, but that the failure of isoprenaline to produce an inhibitory effect could be due to diminished numbers of β‐adrenoceptors and/or increased numbers of α‐adrenoceptors, or to a defect in the coupling of the receptors to the adenylate cyclase system. Alternatively, the presence of an endogenous antagonist of the effects of isoprenaline (for example, an eicosanoid), could mask its inhibitory effects. 7. The absence of an inhibitory effect of isoprenaline on some specimens of human gravid myometrium could have clinical implications, in view of the widespread use of β2‐adrenoceptor agonists as uterine relaxants.</description><identifier>ISSN: 0305-1870</identifier><identifier>EISSN: 1440-1681</identifier><identifier>DOI: 10.1111/j.1440-1681.1988.tb01130.x</identifier><identifier>PMID: 3271633</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Adenylyl Cyclases - metabolism ; adrenaline ; Colforsin - pharmacology ; Epinephrine - pharmacology ; Female ; forskolin ; human ; Humans ; isoprenaline ; Isoproterenol - pharmacology ; myometrium ; Myometrium - drug effects ; Pregnancy ; Uterine Contraction - drug effects ; uterine relaxant ; α-adrenoceptors ; β-adrenoceptors</subject><ispartof>Clinical and experimental pharmacology &amp; physiology, 1988-09, Vol.15 (9), p.703-713</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4383-2d44720a19fd689fccf0827c8dcc08b7d652e649e203f10f98866af423cdabe73</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1440-1681.1988.tb01130.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1440-1681.1988.tb01130.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3271633$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Story, Margot E.</creatorcontrib><creatorcontrib>Hall, Solveiga</creatorcontrib><creatorcontrib>Ziccone, Sebastian P.</creatorcontrib><creatorcontrib>Paull, John D.</creatorcontrib><title>EFFECTS OF ADRENALINE, ISOPRENALINE AND FORSKOLIN ON PREGNANT HUMAN MYOMETRIAL PREPARATIONS</title><title>Clinical and experimental pharmacology &amp; physiology</title><addtitle>Clin Exp Pharmacol Physiol</addtitle><description>SUMMARY 1. The effects of adrenaline, isoprenaline and forskolin upon the evoked contractions of field‐stimulated preparations of human, pregnant, isolated myometrium have been examined. Specimens were obtained at lower segment Caesarean section from patients at 31 (n= 1) and 36–40 (n= 10) weeks of gestation. 2. Adrenaline enhanced the electrically evoked contractions of all preparations studied, indicating that its predominant action on these pregnant myometrial tissues was at α‐and not β‐adrenoceptors. 3. Isoprenaline in concentrations at and below 10 μmol/1 produced inhibitory effects in eight of 11 experiments. In the remaining three experiments, tissues were not responsive to the inhibitory effects of isoprenaline. 4. In all preparations exposed to higher concentrations of isoprenaline (30 or 100 μmol/1), its effects were excitatory. 5. Forskolin produced inhibitory effects on preparations from all uteri, including those from which tissues unresponsive to isoprenaline had been obtained. 6. It is suggested that forskolin in the concentrations which were effective in this study produced its inhibitory effects largely through activation of adenylate cyclase. This implies that the lack of an inhibitory response of some preparations to isoprenaline was not due to reduced activity of the adenylate cyclase system, but that the failure of isoprenaline to produce an inhibitory effect could be due to diminished numbers of β‐adrenoceptors and/or increased numbers of α‐adrenoceptors, or to a defect in the coupling of the receptors to the adenylate cyclase system. Alternatively, the presence of an endogenous antagonist of the effects of isoprenaline (for example, an eicosanoid), could mask its inhibitory effects. 7. The absence of an inhibitory effect of isoprenaline on some specimens of human gravid myometrium could have clinical implications, in view of the widespread use of β2‐adrenoceptor agonists as uterine relaxants.</description><subject>Adenylyl Cyclases - metabolism</subject><subject>adrenaline</subject><subject>Colforsin - pharmacology</subject><subject>Epinephrine - pharmacology</subject><subject>Female</subject><subject>forskolin</subject><subject>human</subject><subject>Humans</subject><subject>isoprenaline</subject><subject>Isoproterenol - pharmacology</subject><subject>myometrium</subject><subject>Myometrium - drug effects</subject><subject>Pregnancy</subject><subject>Uterine Contraction - drug effects</subject><subject>uterine relaxant</subject><subject>α-adrenoceptors</subject><subject>β-adrenoceptors</subject><issn>0305-1870</issn><issn>1440-1681</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1988</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqVkUFP4zAQhS20iC0sP2Elaw97ImEcJ7a7BySrJCWidao07Gq1Byt1HKmlpRC3ovx7ErX0inYuo9Gb-Sy_h9APAj5p63rhkzAEjzBBfNIXwt_MgBAK_u4E9Y7SF9QDCpFHBIev6Ny5BQBEwOgZOqMBJ4zSHvoXJ0k8KKY4S7C8zWMlR6mKr3A6zSYfE5bqFidZPr3P2hFnCrfSUElV4LuHsVR4_Dcbx0WeylGnTGQuizRT02_otC6Xzl4e-gV6SOJicOeNsmE6kCPPhFRQL6jCkAdQkn5dMdGvjalBBNyIyhgQM16xKLAs7NsAaE2gbj_MWFmHATVVObOcXqCfe-5zs37ZWrfRq7kzdrksn-x66zQXojVCiE8XSUSi1qKO-Gu_aJq1c42t9XMzX5XNmyaguwj0Qnc-685n3UWgDxHoXXv8_fDKdray1fH04Hmr3-z11_nSvv0HWQ_iCYcO4O0Bc7exuyOgbB4145RH-o8a6kkekeS3CPQ9fQer_pyP</recordid><startdate>198809</startdate><enddate>198809</enddate><creator>Story, Margot E.</creator><creator>Hall, Solveiga</creator><creator>Ziccone, Sebastian P.</creator><creator>Paull, John D.</creator><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>8FD</scope><scope>FR3</scope><scope>M7Z</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>198809</creationdate><title>EFFECTS OF ADRENALINE, ISOPRENALINE AND FORSKOLIN ON PREGNANT HUMAN MYOMETRIAL PREPARATIONS</title><author>Story, Margot E. ; Hall, Solveiga ; Ziccone, Sebastian P. ; Paull, John D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4383-2d44720a19fd689fccf0827c8dcc08b7d652e649e203f10f98866af423cdabe73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1988</creationdate><topic>Adenylyl Cyclases - metabolism</topic><topic>adrenaline</topic><topic>Colforsin - pharmacology</topic><topic>Epinephrine - pharmacology</topic><topic>Female</topic><topic>forskolin</topic><topic>human</topic><topic>Humans</topic><topic>isoprenaline</topic><topic>Isoproterenol - pharmacology</topic><topic>myometrium</topic><topic>Myometrium - drug effects</topic><topic>Pregnancy</topic><topic>Uterine Contraction - drug effects</topic><topic>uterine relaxant</topic><topic>α-adrenoceptors</topic><topic>β-adrenoceptors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Story, Margot E.</creatorcontrib><creatorcontrib>Hall, Solveiga</creatorcontrib><creatorcontrib>Ziccone, Sebastian P.</creatorcontrib><creatorcontrib>Paull, John D.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biochemistry Abstracts 1</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical and experimental pharmacology &amp; physiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Story, Margot E.</au><au>Hall, Solveiga</au><au>Ziccone, Sebastian P.</au><au>Paull, John D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>EFFECTS OF ADRENALINE, ISOPRENALINE AND FORSKOLIN ON PREGNANT HUMAN MYOMETRIAL PREPARATIONS</atitle><jtitle>Clinical and experimental pharmacology &amp; physiology</jtitle><addtitle>Clin Exp Pharmacol Physiol</addtitle><date>1988-09</date><risdate>1988</risdate><volume>15</volume><issue>9</issue><spage>703</spage><epage>713</epage><pages>703-713</pages><issn>0305-1870</issn><eissn>1440-1681</eissn><abstract>SUMMARY 1. The effects of adrenaline, isoprenaline and forskolin upon the evoked contractions of field‐stimulated preparations of human, pregnant, isolated myometrium have been examined. Specimens were obtained at lower segment Caesarean section from patients at 31 (n= 1) and 36–40 (n= 10) weeks of gestation. 2. Adrenaline enhanced the electrically evoked contractions of all preparations studied, indicating that its predominant action on these pregnant myometrial tissues was at α‐and not β‐adrenoceptors. 3. Isoprenaline in concentrations at and below 10 μmol/1 produced inhibitory effects in eight of 11 experiments. In the remaining three experiments, tissues were not responsive to the inhibitory effects of isoprenaline. 4. In all preparations exposed to higher concentrations of isoprenaline (30 or 100 μmol/1), its effects were excitatory. 5. Forskolin produced inhibitory effects on preparations from all uteri, including those from which tissues unresponsive to isoprenaline had been obtained. 6. It is suggested that forskolin in the concentrations which were effective in this study produced its inhibitory effects largely through activation of adenylate cyclase. This implies that the lack of an inhibitory response of some preparations to isoprenaline was not due to reduced activity of the adenylate cyclase system, but that the failure of isoprenaline to produce an inhibitory effect could be due to diminished numbers of β‐adrenoceptors and/or increased numbers of α‐adrenoceptors, or to a defect in the coupling of the receptors to the adenylate cyclase system. Alternatively, the presence of an endogenous antagonist of the effects of isoprenaline (for example, an eicosanoid), could mask its inhibitory effects. 7. The absence of an inhibitory effect of isoprenaline on some specimens of human gravid myometrium could have clinical implications, in view of the widespread use of β2‐adrenoceptor agonists as uterine relaxants.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>3271633</pmid><doi>10.1111/j.1440-1681.1988.tb01130.x</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0305-1870
ispartof Clinical and experimental pharmacology & physiology, 1988-09, Vol.15 (9), p.703-713
issn 0305-1870
1440-1681
language eng
recordid cdi_proquest_miscellaneous_78803088
source MEDLINE; Wiley Blackwell Single Titles
subjects Adenylyl Cyclases - metabolism
adrenaline
Colforsin - pharmacology
Epinephrine - pharmacology
Female
forskolin
human
Humans
isoprenaline
Isoproterenol - pharmacology
myometrium
Myometrium - drug effects
Pregnancy
Uterine Contraction - drug effects
uterine relaxant
α-adrenoceptors
β-adrenoceptors
title EFFECTS OF ADRENALINE, ISOPRENALINE AND FORSKOLIN ON PREGNANT HUMAN MYOMETRIAL PREPARATIONS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T15%3A58%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=EFFECTS%20OF%20ADRENALINE,%20ISOPRENALINE%20AND%20FORSKOLIN%20ON%20PREGNANT%20HUMAN%20MYOMETRIAL%20PREPARATIONS&rft.jtitle=Clinical%20and%20experimental%20pharmacology%20&%20physiology&rft.au=Story,%20Margot%20E.&rft.date=1988-09&rft.volume=15&rft.issue=9&rft.spage=703&rft.epage=713&rft.pages=703-713&rft.issn=0305-1870&rft.eissn=1440-1681&rft_id=info:doi/10.1111/j.1440-1681.1988.tb01130.x&rft_dat=%3Cproquest_cross%3E15150057%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=15150057&rft_id=info:pmid/3271633&rfr_iscdi=true